print_label | resize_label

Partnering

Spirogen PBD Research Collaborations & Partnerships1

COMPANY YEAR DESCRIPTION
Regeneron Pharmaceuticals 2016 License to develop PBD ADCs
Mitsubishi Tanabe Pharma (MTPC) 2015 License to develop PBD ADCs
AstraZeneca/MedImmune 2013 Acquisition
AstraZeneca/MedImmune 2013 License to develop PBD ADCs
Kolltan Pharmaceuticals 2013 License to develop PBD ADCs
ADC Therapeutics 2012 License to develop specific ADC programs
Genentech 2011 License and multi-year research collaboration
Auven Therapeutics 2009 Option to acquire SG2000 post-P2
Seattle Genetics 2008 License to develop PBD ADCs

1Publicly disclosed